Eric S. Hoffman

Eric S. Hoffman, PhD, is a seasoned professional in the biotechnology and pharmaceutical industries with extensive experience in business development and strategic advisory roles. Currently serving as a Strategic & Scientific Advisor at CureSHANK and Senior Vice President of Business Development at Fusion Pharmaceuticals, Eric has previously held leadership positions at Boulevard Biotech Consulting, Vicarius Pharma, and Genocea Biosciences. Eric's career also includes significant roles at Idenix Pharmaceuticals and Biogen Idec, along with foundational experiences as an equity analyst at JPMorgan and Bear Stearns. Eric holds a Ph.D. in Immunobiology from Yale University and a B.S. in Biology from Trinity University.